Literature DB >> 671078

Long-term intracranial pressure recording in the management of pseudotumor cerebri.

G Gücer, L Viernstein.   

Abstract

Long-term monitoring of intracranial pressure (ICP) was used as an aid for the management of four patients with pseudotumor cerebri. After the implantation of a small experimental pressure sensor in the skull, most of the subsequent (ICP measurements were made noninvasively by an external interrogator. During the initial study of the patient, baseline ICP recordings were made in the hospital before treatment. Pressure recordings on a 24-hour basis were continued during treatment, which, depending on the case, was with Diamox (acetazolamide), steroids, or the coperitoneal shunting. After discharge these patients returned weekly over 10 to 22 months for ICP measurement and for ophthalmological examination. Intracranial pressure before treatment showed irregular variations ranging from 100 to 500 mm H2O over a 24-hour period. The efficacy of treatments could be assessed in a few hours by the degree of ICP stabilization. Shunt malfunction was detected by a slow but continuous rise in pressure before full clinical signs were evident.

Entities:  

Mesh:

Year:  1978        PMID: 671078     DOI: 10.3171/jns.1978.49.2.0256

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  22 in total

Review 1.  Spontaneous retinal venous pulsation: aetiology and significance.

Authors:  A S Jacks; N R Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

2.  CSF pressure, papilledema grade, and response to acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial.

Authors:  Jorge C Kattah; John H Pula; Luis J Mejico; Michael P McDermott; Mark J Kupersmith; Michael Wall
Journal:  J Neurol       Date:  2015-07-10       Impact factor: 4.849

Review 3.  Diagnosis and management of benign intracranial hypertension.

Authors:  D Soler; T Cox; P Bullock; D M Calver; R O Robinson
Journal:  Arch Dis Child       Date:  1998-01       Impact factor: 3.791

4.  Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.

Authors:  Michael Wall; Michael P McDermott; Karl D Kieburtz; James J Corbett; Steven E Feldon; Deborah I Friedman; David M Katz; John L Keltner; Eleanor B Schron; Mark J Kupersmith
Journal:  JAMA       Date:  2014 Apr 23-30       Impact factor: 56.272

5.  The idiopathic intracranial hypertension treatment trial: clinical profile at baseline.

Authors:  Michael Wall; Mark J Kupersmith; Karl D Kieburtz; James J Corbett; Steven E Feldon; Deborah I Friedman; David M Katz; John L Keltner; Eleanor B Schron; Michael P McDermott
Journal:  JAMA Neurol       Date:  2014-06       Impact factor: 18.302

Review 6.  Update on the Diagnosis and Treatment of Idiopathic Intracranial Hypertension.

Authors:  Sarah R Ahmad; Heather E Moss
Journal:  Semin Neurol       Date:  2019-12-17       Impact factor: 3.420

7.  Ocular ultrasound for monitoring pseudotumor cerebri syndrome.

Authors:  Piergiorgio Lochner; Klaus Fassbender; Martin Lesmeister; Raffaele Nardone; Andrea Orioli; Francesco Brigo; Erwin Stolz
Journal:  J Neurol       Date:  2017-12-14       Impact factor: 4.849

Review 8.  Update on Idiopathic Intracranial Hypertension.

Authors:  Michael Wall
Journal:  Neurol Clin       Date:  2017-02       Impact factor: 3.806

9.  Clinical spectrum of the pseudotumor cerebri complex in children.

Authors:  Daniel Tibussek; Dominik T Schneider; Nicola Vandemeulebroecke; Bernd Turowski; Martina Messing-Juenger; Peter H G M Willems; Ertan Mayatepek; Felix Distelmaier
Journal:  Childs Nerv Syst       Date:  2009-11-10       Impact factor: 1.475

10.  Glaucomatouslike visual field defects in chronic papilledema.

Authors:  F Grehn; S Knorr-Held; G Kommerell
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.